DSS, INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
DSS$0.45-8.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| 2024 | 2023 | |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | $(53,706,000) | $(77,524,000) |
| Loss from discontinued operations | - | (3,481,000) |
| Loss from continuing operations | (53,706,000) | (74,043,000) |
| Adjustments to reconcile net loss to net cash used by operating activities: | ||
| Depreciation and amortization | 2,239,000 | 5,206,000 |
| Stock based compensation | 19,000 | - |
| Loss (income) on equity method investment | (1,000) | 34,000 |
| Loss (gain) on investments | (224,000) | 7,307,000 |
| Change in ROU assets | 745,000 | 1,009,000 |
| Impairment of fixed assets | 264,000 | - |
| Impairment of real estate | 7,288,000 | 812,000 |
| Impairment of investments | 782,000 | - |
| (Gain) loss on sale of assets | (14,000) | 1,300,000 |
| Impairment of intangible assets | - | 7,418,000 |
| Impairment of accounts receivable | - | 3,023,000 |
| Impairment of notes receivable | 4,398,000 | 3,794,000 |
| Impairment of assets upon deconsolidation | 6,220,000 | |
| Impairment of goodwill | 25,093,000 | 30,978,000 |
| Decrease (increase) in assets: | ||
| Accounts receivable | 1,142,000 | 1,316,000 |
| Inventory | 377,000 | 5,483,000 |
| Prepaid expenses and other current assets | 778,000 | 996,000 |
| Other assets | (65,000) | 2,392,000 |
| Increase (decrease) in liabilities: | ||
| Accounts payable | (861,000) | (2,260,000) |
| Accrued expenses and deferred revenue | 140,000 | (15,646,000) |
| Change in ROU liabilities | (686,000) | (1,013,000) |
| Other liabilities | 3,210,000 | (39,000) |
| Net cash used by operating activities - continuing operations | (9,082,000) | (15,713,000) |
| Net cash used by operating activities - discontinued operations | - | (3,481,000) |
| Net cash used by operating activities | (9,082,000) | (19,194,000) |
| Cash flows from investing activities: | ||
| Purchase of property, plant and equipment | (133,000) | (818,000) |
| Purchases of real estate assets | (140,000) | |
| Purchase of investment | (3,327,000) | - |
| Disposal of property, plant and equipment | 5,609,000 | 248,000 |
| Asset acquired with Sentinel acquisition | - | 40,000 |
| Sale of marketable securities | 3,023,000 | 9,502,000 |
| Issuance of new notes receivable, net origination fees | (459,000) | (1,046,000) |
| Payments received on notes receivable | 4,132,000 | 870,000 |
| Payments received on notes receivable, related party | 106,000 | 140,000 |
| Net cash provided by investing activities | 8,811,000 | 8,936,000 |
| Cash flows from financing activities: | ||
| Payments of long-term debt | (2,626,000) | (4,246,000) |
| Borrowings of long-term debt | 4,524,000 | 1,829,000 |
| Issuances of common stock, net of issuance costs | 3,189,000 | - |
| Net cash provided (used) by financing activities | 5,087,000 | (2,417,000) |
| Net increase (decrease) in cash - continuing operations | 4,816,000 | (9,194,000) |
| Net increase (decrease) in cash - discontinued operations | - | (3,481,000) |
| Cash and cash equivalents at beginning of year | 6,615,000 | 19,290,000 |
| Cash and cash equivalents at end of year | $11,431,000 | $6,615,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.